Edgewise Therapeutics EWTX
NASDAQ EWTX
$39.34 -0.65 (-1.63%)
As of: Oct 23, 2026 · 3:59 PM EDT

Edgewise Therapeutics (EWTX) Amortization of Deferred Charges (2022 - 2026)

Updated

Analysis

Edgewise Therapeutics (EWTX) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Edgewise Therapeutics 4.24 Bn 2.66 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56,000.00
Mar 31, 2026 53,000.00
Dec 31, 2025 50,000.00
Sep 30, 2025 47,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 41,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 63,000.00
Jun 30, 2024 54,000.00
Mar 31, 2024 52,000.00
Dec 31, 2023 50,000.00
Sep 30, 2023 48,000.00
Jun 30, 2023 37,000.00
Mar 31, 2023 46,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 65,000.00
Jun 30, 2022 57,000.00
Mar 31, 2022 44,000.00
API Access

Edgewise Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=EWTX&period=max&api_key=YOUR_API_KEY